Bioengineer Gang Bao uses gene editing to repair up to 40 percent of bone marrow cells from patients
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
Bao’s lab collaborated with Vivien Sheehan, an assistant professor of pediatrics and hematology at Baylor and a member of the sickle cell program at Texas Children’s, to collect stem and progenitor cells (CD34-positive cells) from patients with the disease. These were then edited in the Bao lab with CRISPR/Cas9 together with a custom template, a piece of DNA designed to correct the mutation.
The gene-edited cells were injected into the bone marrow of immunodeficient mice and tested after 19 weeks to see how many retained the edit. “The rate of repair remained stable, which is great,” Bao said. This engraftment study was carried out in the lab of Matt Porteus, an associate professor of pediatrics at Stanford.
Another major finding of the study is that the CRISPR/Cas9 system could introduce large alterations to the genes in patients’ cells, in addition to small mutations or deletions. These off-target effects could cause a disease.
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
Learn more: Rice U. reports progress in pursuit of sickle cell cure
The Latest on: Sickle cell disease
[google_news title=”” keyword=”Sickle cell disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sickle cell disease
- Young New Orleans sickle cell patient is leaving pain behind after a bone marrow transplanton April 22, 2024 at 5:44 am
At only 12 years old, Kelsey Farris already has endured periods of searing pain, endless rounds of medical tests and several lengthy stays at Children’s Hospital in New Orleans. But ...
- Jinja Hospital aims at genetic screening to tame sickle cell diseaseon April 21, 2024 at 6:01 am
Jinja Regional Referral Hospital (JRRH) authorities have announced plans to start genetic screening among couples ...
- Malaria’s Double Threat: Understanding the Interplay With Sickle Cell Anaemia in Rural Indiaon April 20, 2024 at 8:19 pm
Delving into the connection between Malaria and Sickle Cell Anemia in India's rural spaces unravels a complicated interaction. Read on to know more.
- Sickle Cell and Hearing Losson April 19, 2024 at 5:01 pm
Sickle cell disease is a genetic blood disorder affecting red blood cells. It is characterized by the presence of abnormal haemoglobin, which causes red blood cells to take on a sickle-like shape, ...
- Food is Medicine: Brooklyn And Sickle Cell Diseaseon April 16, 2024 at 9:13 am
Among the bustling streets that epitomize New York City's energy, thousands of residents are too sick to leave their homes. They grapple with diagnoses that severely impede their daily routines and ...
- Missouri, give sickle cell disease patients a better chance with new gene therapies | Opinionon April 16, 2024 at 2:08 am
Rosemary Britts’ daughter Ro lost her battle at the age of 29. The state should open up access to treatment options that could have helped her. | Opinion ...
- Potential Treatment To Manage Sickle Cell Complications Identifiedon April 12, 2024 at 1:21 am
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, reports a new study.
- Safety of a potential new treatment to manage complications from sickle cell diseaseon April 11, 2024 at 4:14 pm
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study. An early phase ...
- Researchers identify safety of a potential new treatment to manage complications from sickle cell diseaseon April 11, 2024 at 10:05 am
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in ...
- Medicare floats incentive for hospitals to offer new sickle cell treatmentson April 11, 2024 at 3:00 am
Hospitals within months could get extra federal money to administer pricey new gene therapies for sickle cell disease, including the first CRISPR-based treatment.
via Bing News